FDA revisits safety of CBD for use in dietary supplements, industry not satisfied
Last week’s meeting of the U.S. Food and Drug Administration’s Science Board did little to assuage a frustrated CBD industry that continues to call for regulation of the cannabinoid as a dietary supplement.